Journal article icon

Journal article

TNFR2: The new Treg switch?

Abstract:
Three recent publications identified the TNF/TNR2 pathway as a new target to reduce graft-versus-host-disease through regulatory T cells activation or to potentially switch on a strong anti-leukemic effect through regulatory T cells blockade in allogeneic hematopoietic stem cell transplantation. This identified the TNF/TNR2 pathway as a swith and as a new target for immune checkpoint therapy to modulate the immune regulation in this clinical setting.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1080/2162402X.2017.1373236

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Surgical Sciences
Oxford college:
Green Templeton College
Role:
Author


Publisher:
Taylor and Francis
Journal:
OncoImmunology More from this journal
Volume:
7
Issue:
1
Article number:
e1373236
Publication date:
2017-09-21
Acceptance date:
2017-08-25
DOI:
ISSN:
2162-402X
Pmid:
29296530


Language:
English
Keywords:
Pubs id:
pubs:731195
UUID:
uuid:b57eac31-a8d1-4a9f-830e-41d42fe9ce57
Local pid:
pubs:731195
Source identifiers:
731195
Deposit date:
2018-08-14
ARK identifier:

Terms of use


Views and Downloads

Views and downloads will return soon






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP